WST logo

WST

Profile

Full Name

West Pharmaceutical Services, Inc.

Ticker Symbol

WST

Exchange

NYSE

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

United States

IPO

March 17, 1980

Indexes

S&P 500

Website

http://www.westpharma.com

Employees

10600

Key Details

Price

$212.50(-0.08%)

Market cap

Last Dividend

$0.21

TTM Dividend yield

0.39%

Annual revenue

$2.89B(-1.92% YoY)

Annual EPS

$6.69(-15.10% YoY)

PE ratio

31.76

Next earnings date

Apr 24, 2025

Next ex-dividend date

Apr 30, 2025

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$212.50
WST price is $212.50

30-Day Relative Volume

0.63
WST 30-day relative volume is 0.63

Price Performance

Price Today change

-0.08%
WST price is down -0.08% today

Price YTD change

-35.13%
WST price is down -35.13% since January 1st

Price 1-year change

-43.9%
WST price is down -43.9% year-on-year

Price 3-year change

-44.26%
WST price is down -44.26% over the past 3 years

Price Range

Price All-time high

$475.35
WST price is currently -55.30% below its historical high of $475.35

Price 3-year low

$187.43
WST price is currently +13.38% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$15.36B
WST market capitalization is $15.36 billion

Market cap 3-year change

-45.59%
WST market capitalization is down -45.59% over the past 3 years

Market cap All-time high

$34.92B
WST market capitalization is currently -56.00% below its historical high of $34.92 billion

Market cap sector rank

94.9%
WST market capitalization is higher than 94.9% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-0.95%
WST shares outstanding is down -0.95% year-on-year

Shares Outstanding 3-Year Change

-2.42%
WST shares outstanding is down -2.42% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.50
WST beta is 0.50

200-day SMA

$294.53
WST price is currently -27.85% below its 200-day simple moving average

50-day SMA

$234.70
WST price is currently -9.46% below its 50-day simple moving average

RSI

43.36
WST 14-day relative strength index is 43.36

Volume

0.63
WST 30-day relative volume is 0.63

ATR

$10.05
WST average true range is $10.05

10-day Historical Volatility

64.65%
WST 10-day historical volatility is 64.65%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.21
WST last dividend was $0.21 per share, with an ex-dividend date of February 7, 2025

Next Dividend

$0.21
WST has announced a dividend of $0.21 per share, with an ex-dividend date set for April 30, 2025

Dividend per share

Dividend per share

$0.81
WST annual dividend per share is $0.81

Dividend per share Sector Rank

33.72%
WST annual dividend per share is higher than 33.72% of companies in Healthcare sector

Dividend per share 1-Year Change

+5.19%
WST annual dividend per share is up +5.19% year-on-year

Dividend per share 3-Year Change

+17.39%
WST annual dividend per share is up +17.39% over the past 3 years

Dividend yield

Dividend yield

0.38%
WST annual dividend yield is 0.38%

Dividend yield Sector Rank

10.59%
WST annual dividend yield is higher than 10.59% of companies in Healthcare sector

Other

Payout ratio

12.00%
WST annual payout ratio is 12.00%

Dividends paid

$59.10M
WST annual dividends paid is $59.10 million

Free cash flow

$276.40M
WST annual free cash flow is $276.40 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$2.89B
WST annual revenue is $2.89 billion

Revenue Analysts estimate

$2.90B
WST annual revenue is currently -0.11% lower than the consensus analysts' forecast

Revenue 1-year change

-1.92%
WST annual revenue is down -1.92% year-on-year

Revenue Sector rank

88.24%
WST annual revenue is higher than 88.24% of companies in Healthcare sector

EPS

EPS

$6.69
WST annual earnings per share is $6.69

EPS Analysts estimate

$6.19
WST annual earnings per share is currently +8.04% higher than the consensus analysts' forecast

EPS 1-year change

-15.1%
WST annual earnings per share is down -15.1% year-on-year

EPS Sector rank

96.86%
WST annual earnings per share is higher than 96.86% of companies in Healthcare sector

Profit

Gross profit

$998.50M
WST annual gross profit is $998.50 million

Gross margin

34.51%
WST annual gross profit margin is 34.51%

Operating profit

$569.90M
WST annual operating income is $569.90 million

Operating margin

19.70%
WST annual operating profit margin is 19.70%

Net income

$492.70M
WST annual net profit is $492.70 million

Net margin

17.03%
WST annual net profit margin is 17.03%

Expenses

Total expenses

$2.32B
WST annual total expenses is $2.32 billion

Operating expenses

$428.60M
WST annual total operating expenses is $428.60 million

Cost of goods sold

$1.89B
WST annual cost of goods sold is $1.89 billion

Selling, general & administrative expenses

$338.50M
WST annual SGA is $338.50 million

Depreciation and amortization

$155.40M
WST annual depreciation & amortization is $155.40 million

Interest expense

$3.00M
WST annual interest expense is $3.00 million

Income tax

$107.50M
WST annual income tax is $107.50 million

EBIT & EBITDA

EBIT

$569.90M
WST annual earnings before interest & taxes is $569.90 million

EBITDA

$725.30M
WST annual EBITDA is $725.30 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$3.64B
WST annual total assets is $3.64 billion

Non current assets

$2.11B
WST annual long term assets is $2.11 billion

Current assets

$1.41B
WST annual total current assets is $1.41 billion

Cash and cash equivalents

$484.60M
WST annual cash & cash equivalents is $484.60 million

Accounts receivable

$552.50M
WST annual accounts receivable is $552.50 million

Inventory

$377.00M
WST annual inventory is $377.00 million

Liabilities

Total liabilities

$961.10M
WST annual total liabilities is $961.10 million

Long term liabilities

$410.70M
WST annual total long term liabilities is $410.70 million

Current liabilities

$239.30M
WST annual total current liabilities is $239.30 million

Accounts payable

$239.30M
WST annual accounts payable is $239.30 million

Debt

Total debt

$302.30M
WST annual total debt is $302.30 million

Total debt 1-year change

-2.17%
WST annual total debt is down -2.17% year-on-year

Long term debt

$284.40M
WST annual long term debt is $284.40 million

Short term debt

$17.90M
WST annual short term debt is $17.90 million

Equity & Capital

Shareholders equity

$2.68B
WST annual stockholders equity is $2.68 billion

Book value

$2.68B
WST annual book value is $2.68 billion

Retained earnings

$3.96B
WST annual retained earnings is $3.96 billion

Working capital

$1.17B
WST annual working capital is $1.17 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$653.40M
WST annual cash flow from operations is $653.40 million

Cash from operations 1-year change

-15.85%
WST annual cash flow from operations is down -15.85% year-on-year

Cash from investing

-$378.70M
WST annual cash flow from investing activities is -$378.70 million

Cash from investing 1-year change

-2.71%
WST annual cash flow from investing activities is down -2.71% year-on-year

Cash from financing

-$622.60M
WST annual cash flow from financing activities is -$622.60 million

Cash from financing 1-year change

-35.47%
WST annual cash flow from financing activities is down -35.47% year-on-year

CAPEX

CAPEX

$377.00M
WST annual capital expenditures is $377.00 million

CAPEX 1-year change

+4.14%
WST annual capital expenditures is up +4.14% year-on-year

Free Cash Flow

Free cash flow

$276.40M
WST annual free cash flow is $276.40 million

Free cash flow 1-year change

-33.32%
WST annual free cash flow is down -33.32% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

34.51%
WST annual gross profit margin is 34.51%

Operating margin

19.70%
WST annual operating profit margin is 19.70%

Net margin

17.03%
WST annual net profit margin is 17.03%

ROA & ROE

ROA

13.19%
WST annual return on assets is 13.19%

ROE

17.71%
WST annual return on equity is 17.71%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

31.76
WST price to earnings ratio is 31.76

PE ratio Sector rank

63.24%
WST price to earnings ratio is higher than 63.24% of companies in Healthcare sector

PB Ratio

PB ratio

5.73
WST price to book ratio is 5.73

PB ratio Sector rank

85.35%
WST price to book ratio is higher than 85.35% of companies in Healthcare sector

PS Ratio

PS ratio

5.31
WST price to sales ratio is 5.31

PS ratio Sector rank

66.92%
WST price to sales ratio is higher than 66.92% of companies in Healthcare sector

Enterprise value

Enterprise value

$15.18B
WST enterprise value is $15.18 billion

Enterprise value Sector rank

94.13%
WST enterprise value is higher than 94.13% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

20.53
WST EV/EBITDA is 20.53

EV/EBITDA Sector rank

91.91%
WST EV/EBITDA is higher than 91.91% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

5.91
WST annual current ratio is 5.91

Quick ratio

4.33
WST annual quick ratio is 4.33

Leverage

Debt to equity

0.00
WST annual debt to equity ratio is 0.00

Interest coverage ratio

189.97
WST annual interest coverage ratio is 189.97

Risk & Stability

Piotroski F-Score

6
WST piotroski f-score is 6

Altman Z-Score

12.81
WST altman z-score is 12.81

Analyst ratings

Recent major analysts updates

Mar 18, 25 Evercore ISI Group
Outperform
Feb 14, 25 Keybanc
Overweight
Jan 8, 25 Citigroup
Buy
Dec 13, 24 Wolfe Research
Peer Perform
Dec 13, 24 B of A Securities
Buy
Dec 12, 24 UBS
Buy
Feb 16, 24 UBS
Neutral
Feb 13, 24 Keybanc
Overweight
Feb 7, 24 Jefferies
Buy
Oct 27, 23 Stephens & Co.
Overweight

Institutional Ownership

Similar stocks

COO logo
Cooper Companies (COO)
TEVA logo
Teva Pharmaceutical Industries Limited (TEVA)
FMS logo
Fresenius Medical Care AG & Co KGaA (FMS)
BAX logo
Baxter International (BAX)
RPRX logo
Royalty Pharma (RPRX)
ITCI logo
Intra-Cellular Therapies (ITCI)
BIIB logo
Biogen (BIIB)
HOLX logo
Hologic (HOLX)
INSM logo
Insmed Incorporated (INSM)
  • What is the ticker symbol for West Pharmaceutical Services?
  • Does West Pharmaceutical Services pay dividends?
  • What sector is West Pharmaceutical Services in?
  • What industry is West Pharmaceutical Services in?
  • What country is West Pharmaceutical Services based in?
  • When did West Pharmaceutical Services go public?
  • Is West Pharmaceutical Services in the S&P 500?
  • Is West Pharmaceutical Services in the NASDAQ 100?
  • Is West Pharmaceutical Services in the Dow Jones?
  • When was West Pharmaceutical Services's last earnings report?
  • When does West Pharmaceutical Services report earnings?
  • Should I buy West Pharmaceutical Services stock now?

What is the ticker symbol for West Pharmaceutical Services?

The ticker symbol for West Pharmaceutical Services is NYSE:WST

Does West Pharmaceutical Services pay dividends?

Yes, West Pharmaceutical Services pays dividends. The last payment was $0.21, with an ex-dividend date on February 7, 2025

What sector is West Pharmaceutical Services in?

West Pharmaceutical Services is in the Healthcare sector

What industry is West Pharmaceutical Services in?

West Pharmaceutical Services is in the Medical Instruments & Supplies industry

What country is West Pharmaceutical Services based in?

West Pharmaceutical Services is headquartered in United States

When did West Pharmaceutical Services go public?

West Pharmaceutical Services's initial public offering (IPO) was on March 17, 1980

Is West Pharmaceutical Services in the S&P 500?

Yes, West Pharmaceutical Services is included in the S&P 500 index

Is West Pharmaceutical Services in the NASDAQ 100?

No, West Pharmaceutical Services is not included in the NASDAQ 100 index

Is West Pharmaceutical Services in the Dow Jones?

No, West Pharmaceutical Services is not included in the Dow Jones index

When was West Pharmaceutical Services's last earnings report?

West Pharmaceutical Services's most recent earnings report was on Feb 13, 2025

When does West Pharmaceutical Services report earnings?

The next expected earnings date for West Pharmaceutical Services is Apr 24, 2025

Should I buy West Pharmaceutical Services stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page